6 Undervalued Food Products Stocks for Thursday, October 17
Discover the top 6 undervalued Food Products stocks for Thursday, October 17 based on AAII’s Stock Grades.Tudor Pop
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Commentary & Analysis
4 Undervalued Food Processing Stocks for Friday, August 30
Discover the top 4 undervalued Food Processing stocks for Friday, August 30 based on AAII’s Stock Grades.Eunice Kim
7 Undervalued Food Processing Stocks for Tuesday, July 30
Discover the top 7 undervalued Food Processing stocks for Tuesday, July 30 based on AAII’s Stock Grades.Jenna Brashear
3 Undervalued Food Processing Stocks for Friday, June 21
Discover the top 3 undervalued Food Processing stocks for Friday, June 21 based on AAII’s Stock Grades.Jack Gilleland
3 Undervalued Chemicals - Agricultural Stocks for Monday, May 20
Discover the top 3 undervalued Chemicals - Agricultural stocks for Monday, May 20 based on AAII’s Stock Grades.Jenna Brashear
Financial Summary
| Share Statistics | RKDA | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1.1 | $1,637.4 | 1% |
|
| Shares Out (Mil) | 3.0 | 47.6 | 10% |
|
| Institutional Ownership | 88.5% | 50.0% | 56% |
|
| Float (Mil) | 1.9 | 86.0 | 5% |
|
| Beta | 0.55 | 0.34 | 32% |
|
| Avg Daily Volume (000s) | 426 | 63 | 55% |
|
| Price Change (52-week) |
(89.5%) | 76.5% | 4% |
|
| Growth | RKDA | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (9.3%) | 6.4% | 6% |
|
| Net Income (5yr) | 13.3% | 1.4% | 60% |
|
| EPS (5yr) | 38.0% | 2.6% | 87 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.9%) | (15.1%) | 46% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | RKDA | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $5 | $2,514 | 6% |
|
| Net Income (TTM) (Mil) | ($11) | $83 | 28% |
|
| EPS (TTM) | ($5.694) | $0.200 | 7% |
|
| Operating Cash Flow (TTM) (Mil) | ($3) | $236 | 28% |
|
| Net Cash Flow (TTM) (Mil) | na | $4 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $541 | 0% |
|
| Enterprise Value (Q1) (Mil) | ($3) | $2,833 | 3% |
|
| Valuation | RKDA | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.60 | 1.72 | 41% |
|
| P/E | na | 18.3 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | RKDA | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 34.6% | 27.2% | 42% |
|
| Net Margin | (234.5%) | 3.5% | 4% |
|
| ROA | (162.7%) | 3.0% | 3% |
|
| ROE | (430.9%) | 8.4% | 1% |
|
| Liabilities to Assets | 89.3% | 53.7% | 84% |
|
| F-Score | 2 | 4 | 7% |
|
Arcadia Biosciences, Inc. did not pass any screens on 8/20/2026.
